DEUTSCHE BANK AG\
BankPosition in GLUE — Monte Rosa Therapeutics, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in GLUE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,816,475
+$1,029,146 QoQ
Shares Held
75,061
+56.8% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 193 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. GLUE ranks #118 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in GLUE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,816,475 | 75,061 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $787,329 | 47,862 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $519,133 | 33,108 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $182,071 | 24,571 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $84,021 | 18,630 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $115,304 | 24,850 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $201,703 | 29,064 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $118,884 | 22,431 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $40,616 | 10,860 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $94,385 | 13,388 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $78,868 | 13,959 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $66,863 | 13,959 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $95,619 | 13,959 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $204,705 | 26,278 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $197,653 | 25,973 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $191,929 | 23,492 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $130,216 | 13,466 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $225,020 | 16,050 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $143,144 | 7,010 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $171,510 | 7,698 | Shares | Defined | 2021-11-04 | |
| No filing history on record for this holder in this stock. | ||||||